Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  BULK DEALS
Bulk Deals      
Nath Bio-Genes (India) Ltd.
BSE Code 537291
ISIN Demat INE448G01010
Book Value 361.65
NSE Code NATHBIOGEN
Dividend Yield % 1.37
Market Cap 2771.73
P/E 5.88
EPS 24.82
Face Value 10  
 
 
   
Deal DateCompany NameClient NameTranQty.(000's)ValuePriceTrade(Rs.in Lakhs)Close Price
05-Mar-2025 Nath Bio-Genes BAKULESH SHAH PRIVATE TRUSTSELL 168000152.525620000144
05-Mar-2025 Nath Bio-Genes BAKULESH TRAMBAKLAL SHAHBUY 168000152.525620000144
21-Feb-2024 Nath Bio-Genes AGRI TECH INDIA LIMITEDSELL 504000217109368000144
21-Feb-2024 Nath Bio-Genes AKASH FARMS LLPBUY 504000217109368000144
19-Jan-2024 Nath Bio-Genes BAKULESH SHAH PRIVATE TRUSTBUY 20800022947632000144
19-Jan-2024 Nath Bio-Genes KBS PROPERTIES PRIVATE LIMITEDSELL 20800022947632000144
22-Dec-2023 Nath Bio-Genes AGRI TECH INDIA LIMITEDSELL 16880021135616800144
22-Dec-2023 Nath Bio-Genes BARKHA FARMS LLPBUY 16880021135616800144
15-Dec-2023 Nath Bio-Genes AGRI TECH INDIA LIMITEDSELL 311831199.2562132326.75144
15-Dec-2023 Nath Bio-Genes AKASH FARMS LLPBUY 311831199.2562132326.75144
08-Dec-2023 Nath Bio-Genes AGRI TECH INDIA LIMITEDSELL 510500196100058000144
08-Dec-2023 Nath Bio-Genes ASHU FARMS LLPBUY 510500196100058000144
Page 1 of 2
Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.